Equities

OLBA Healthcare Holdings Inc

2689:TYO

OLBA Healthcare Holdings Inc

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,048.00
  • Today's Change11.00 / 0.54%
  • Shares traded2.80k
  • 1 Year change+14.67%
  • Beta0.7241
Data delayed at least 20 minutes, as of May 10 2024 02:19 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

OLBA Healthcare Holdings Inc, formerly Kawanishi Holdings Inc, is a Japan-based company mainly engaged in the medical equipment business. The Company operates through four business segments. The Medical Equipment segment is engaged in the sale of medical electrical equipment, pharmaceuticals, surgical instruments, implants and other medical equipment for clinics and hospitals. The Supply Process Distribution (SPD) segment is engaged in the provision of SPD systems that use information technology to manage goods information and purchase information. The Nursing Care Products segment is engaged in the sale and rental of home care beds and other nursing care equipment. The Import and Sale segment is engaged in the import and sale of medical equipment.

  • Revenue in JPY (TTM)117.02bn
  • Net income in JPY1.50bn
  • Incorporated1967
  • Employees1.32k
  • Location
    OLBA Healthcare Holdings Inc8F, Nihon-Seimei Okayama Bldg II1-1-3, Shimoishii, Kita-kuOKAYAMA-SHI 700-0907JapanJPN
  • Phone+81 862361112
  • Fax+81 862361113
  • Websitehttps://www.olba.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Kowa Co Ltd6.40bn710.43m6.47bn7.87k8.422.306.891.01153.77153.771,379.57563.731.282.757.56--14.506.0623.769.1046.1146.3711.295.390.974913.790.27522.992.167.1962.08---10.57--
Yamashita Health Care Holdings Inc61.84bn660.00m7.07bn570.0010.720.84268.200.1144258.51258.5124,234.433,288.822.5717.485.52108,496,500.002.721.947.505.6113.6311.821.060.70731.05--0.003635.555.53-0.1702-68.54-0.14623.4513.05
Koken Ltd10.59bn701.13m8.33bn287.0011.500.6536.990.7868141.89141.892,142.592,499.090.51162.433.0036,888,940.003.393.704.294.7545.7146.696.627.191.7324.430.328825.88-0.16054.92-15.8414.33-39.876.96
Create Medic Co Ltd12.69bn83.34m9.23bn962.00104.020.568819.920.72729.189.181,395.571,678.910.66781.734.3913,193,190.000.43853.000.51453.5343.6845.360.65674.602.98--0.050363.222.103.11-68.06-25.530.66271.12
DVx Inc46.19bn397.59m10.75bn319.0026.111.1412.990.232738.1938.194,430.49875.082.0024.494.00144,803,700.001.724.044.149.8110.7112.240.86071.891.48--0.0032.014.374.418.481.80-2.355.46
OLBA Healthcare Holdings Inc117.02bn1.50bn12.68bn1.32k8.101.119.990.1084250.44250.4419,539.551,826.782.6616.204.3288,854,800.003.402.7112.139.7811.5811.061.280.91740.9764152.760.162732.162.330.5165-7.896.06-6.4211.84
JMS Co Ltd64.86bn204.00m13.03bn5.65k63.290.32383.390.2018.338.332,651.291,627.390.83862.673.7311,479,120.000.25091.730.35972.5622.4125.130.29912.021.071.840.37134.219.582.43-65.98-14.943.911.22
Techno Medica Co Ltd9.73bn1.23bn14.98bn225.0011.410.901811.131.54149.84149.841,190.251,896.310.58222.413.6343,247,240.007.386.598.357.6449.9248.1612.6712.035.27--0.0039.88-3.421.60-10.20-2.5418.515.92
Medius Holdings Co Ltd247.46bn1.14bn17.05bn2.29k14.830.90746.010.068951.9451.9411,254.21848.562.3317.024.37108,156,900.001.081.644.416.0212.1311.490.46220.58370.896268.940.589931.155.497.29-19.8015.0942.529.46
Daiken Medical Co Ltd9.65bn912.09m17.61bn188.0017.422.3015.661.8331.7531.75335.80240.850.87443.723.5951,314,050.008.277.1812.1210.4739.0542.969.459.251.52509.690.267673.266.991.25-14.32-6.79-20.77-0.9711
HOSHI IRYO-SANKI CO., LTD14.59bn1.38bn17.65bn470.0011.680.9777.661.21441.64441.644,683.445,281.520.686823.495.7631,036,470.006.535.438.216.8948.6749.229.508.332.83--0.0017.697.895.7213.237.7710.738.45
Japan Medical Dynamic Marketing, INC.23.18bn1.27bn17.79bn488.0013.910.69376.130.767648.3048.30880.53968.740.76090.68154.15--4.296.514.927.5363.6966.975.638.882.11--0.055218.268.786.74-10.68-8.52-2.959.24
Seed Co Ltd32.05bn648.96m18.46bn974.0023.531.185.520.576125.9225.921,280.20514.910.7562.447.7632,903,220.001.431.572.542.7942.5542.591.892.120.613226.090.632447.176.101.91-127.39---34.239.86
Data as of May 10 2024. Currency figures normalised to OLBA Healthcare Holdings Inc's reporting currency: Japanese Yen JPY

Institutional shareholders

1.88%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 29 Mar 202447.30k0.76%
Nikko Asset Management Co., Ltd.as of 05 Apr 202422.60k0.36%
Daiwa Asset Management Co. Ltd.as of 29 Mar 202421.60k0.35%
Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Apr 202410.10k0.16%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 20 Apr 20234.00k0.06%
Dimensional Fund Advisors LPas of 04 Apr 20243.80k0.06%
BlackRock Japan Co. Ltd.as of 04 Apr 20242.90k0.05%
Asset Management One Co., Ltd.as of 04 Apr 20242.30k0.04%
Dimensional Fund Advisors Ltd.as of 29 Feb 20241.70k0.03%
Amundi Asset Management SA (Investment Management)as of 03 Apr 2024900.000.01%
More ▼
Data from 31 Dec 2023 - 02 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.